In 2022, the drug generated 1.7 billion ($1.8 billion), reflecting a notable 10 percent increase
doi: 10.1093/gastro/gov062
The new approval for Retevmo, which was previously authorized to treat patients 12 and older with RET-positive thyroid cancers, is based on a single-arm study that showed an overall response rate of 48%, with a median duration of response not reached after 12 months of follow-up
Techniques such as liquid chromatographymass spectrometry (LC-MS), direct infusion mass spectrometry, proximity extension assays (Olink), and aptamer-based assays (SomaScan) enable detection of multidimensional biomarker patterns linked to atherosclerosis progression ( Key findings include identification of lipid species such as ceramides, sphingolipids, and glycerolipids that strongly correlate with atherosclerosis progression and cardiovascular events ( Importantly, these platforms provide a scalable approach to evaluate vascular molecular responses to therapies
Because obesity is closely linked to lymphatic dysfunction, these therapies have the potential to influence how clinicians approach: Lymphedema prevention Chronic edema management Phlebolymphedema treatment Long-term patient outcomes As research evolves, therapists who understand the relationship between weight loss and lymphatic health will be better positioned to provide comprehensive, evidence-based care
ideal for anti-aging and recovery Morning (fasted): Enhances fat-burning effects